Cancer-fighting virus T-VEC helps shrink tough-to-treat skin tumors

Talimogene laherparepvec (T-VEC) demonstrates efficacy in cutaneous BCC, enhancing resectability and altering immune cell composition with low adverse events.

Climate change could exacerbate respiratory disease deaths during warm seasons

Global warming caused by climate change could exacerbate the burden of inpatient mortality from respiratory diseases during the warm season.

November 7, 2023

Can virtual reality be the future of brain health? New research suggests VR exercise enhances working memory

The impact of virtual reality (VR) exercise on brain functioning.

May 13, 2024

BeiGene’s TEVIMBRA receives approval for OSCC in Israel

TEVIMBRA monotherapy is indicated for treating unresectable or metastatic oesophageal squamous cell carcinoma. Credit: SewCreamStudio/Shutterstock. The Israeli Ministry of Health (IL MOH) has approved BeiGene’s

September 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.